Does a high arachidonic acid to EPA ratio favor pro-inflammatory eicosanoid production?

Cellular inflammation is highly regulated by the balance of polyunsaturated fatty acids in cell membranes, specifically the ratio of omega-6 arachidonic acid (AA) to omega-3 eicosapentaenoic acid (EPA).

Membrane-level substrate regulation

• Phospholipid incorporation: High relative concentrations of AA over EPA favor the competitive incorporation of AA into cell membrane phospholipids.
• PLA2 mobilization: Upon cellular activation, Phospholipase A2 (PLA2) releases fatty acids from these membrane stores. Because of upstream membrane composition, high relative AA levels dictate the substrate pool available to compete for downstream enzymes.

Enzymatic competition and eicosanoid synthesis

• COX and LOX active-site kinetics: Free AA and EPA compete directly for the active sites of cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. Because AA is metabolized with superior catalytic efficiency ($k_{cat}/K_m$), a high AA:EPA ratio drives dominant enzymatic binding and turnover of AA.
• Inflammatory mediator shift: Preferential conversion of AA generates highly potent, pro-inflammatory 2-series prostaglandins (such as PGE2) via COX, and 4-series leukotrienes (such as LTB4) via 5-LOX. These mediators promote vasodilation, pain, and neutrophil recruitment. Conversely, a lower ratio allows EPA to successfully compete, shifting synthesis toward less potent 3-series prostanoids and 5-series leukotrienes.

Bottom line

• The cellular ratio of AA to EPA acts as a critical biochemical switch; a high AA:EPA ratio drives preferential membrane mobilization and superior enzymatic turnover of AA, leading to a dominant synthesis of highly potent, pro-inflammatory 2-series and 4-series eicosanoids.